Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 4,757.50 154.76 -43.82 -1,653.59 -28.16 0.02 15.4411 -0.56 -19.8738 -2,513.6549 -10.69 -12.48 845.9088 - -
Maximum - - - - - - 42,031.00 2,663.00 306.00 6,578.00 583.00 0.94 1,336.3467 6.52 300.5100 8,534.8500 14.64 835.37 6,156.2100 - -
Minimum - - - - - - 0.00 0.00 -394.00 -56,335.00 -221.00 0.00 -164.8536 -8.99 -1,674.0000 -144,478.0000 -155.91 -1,263.79 0.0700 - -
Sarepta Therapeutics, Inc. SRPT 125.01 -0.68 -0.54% 622 vs. 1,446 11,921.00 413.00 36.00 -284.00 -4,410.00 0.3800 83.5325 0.00 87.77 8.74 3.76 1.12 297.37 95.00
Seagen Inc. SGEN 228.74 -0.16 -0.07% 19,392 vs. 1,634 43,154.00 648.00 -215.00 -79.00 -2,756.00 -1.1500 -46.2406 0.00 74.52 -33.27 -8.46 -5.94 195.72 188.00
Reata Pharmaceuticals, Inc. RETA 172.36 0.04 0.02% 1,909 vs. 954 6,566.00 22.00 192.00 -70.00 -1,490.00 5.1200 5.4820 0.00 96.28 848.49 221.10 38.40 282.09 38.00
Moderna, Inc. MRNA 69.86 -2.13 -2.96% 4,190 vs. 4,387 26,853.00 167.00 -1,175.00 -1,185.00 12,431.00 -3.0800 -8.5828 0.00 20.96 -703.59 -9.17 -7.02 375.08 384.00
TG Therapeutics, Inc. TGTX 25.25 0.17 0.68% 4,266 vs. 3,210 3,909.00 63.00 -10.00 -8.00 -1,525.00 -0.0732 -50.4229 0.00 91.30 -16.87 -6.69 -2.87 275.64 154.00
Madrigal Pharmaceuticals, Inc. MDGL 233.16 -0.20 -0.09% 150 vs. 282 5,062.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.00 0.00 0.00 -17.34 -13.63 926.23 21.00
Vertex Pharmaceuticals Incorporated VRTX 474.16 -7.10 -1.48% 837 vs. 1,145 122,381.00 2,687.00 1,099.00 1,058.00 11,242.00 4.2600 24.6835 0.00 87.25 40.92 5.93 4.60 315.20 258.00
Regeneron Pharmaceuticals, Inc. REGN 1138.81 -7.94 -0.69% 328 vs. 463 123,466.00 3,145.00 722.00 1,350.00 27,982.00 6.7000 36.1813 0.00 82.58 22.96 2.67 2.10 439.60 108.00
Intellia Therapeutics, Inc. NTLA 22.52 -0.03 -0.13% 1,692 vs. 1,492 2,287.00 28.00 -107.00 -123.00 -1,765.00 -1.1200 -6.0491 0.00 91.32 -371.30 -10.37 -8.53 845.37 101.00
CRISPR Therapeutics AG CRSP 49.59 -0.28 -0.56% 1,668 vs. 1,231 4,223.00 0.00 -116.00 109.00 -1,116.00 -1.4300 -11.9580 0.00 -10177.58 -23133.13 -5.59 -4.78 1771.68 85.00
Novo Nordisk A/S NVO 132.06 0.06 0.05% 2,692 vs. 3,791 595,163.00 65,349.00 25,407.00 5,305.00 99,050.00 5.7000 38.8598 0.72 84.83 38.88 25.69 8.50 43.72 4,506.00
CureVac N.V. CVAC 3.29 0.01 0.30% 310 vs. 801 737.00 12.00 -70.00 -101.00 -1,636.00 -0.3100 -2.2038 0.00 -236.94 -570.22 -15.79 -10.22 203.71 224.00
BioMarin Pharmaceutical Inc. BMRN 71.14 0.59 0.84% 2,162 vs. 2,212 13,543.00 648.00 88.00 12.00 -532.00 0.4700 46.3847 0.00 78.50 13.66 1.75 1.29 154.77 190.00
Alnylam Pharmaceuticals, Inc. ALNY 273.15 -1.31 -0.48% 567 vs. 1,229 35,067.00 494.00 -65.00 -94.00 -7,075.00 -0.5200 -73.3326 0.00 86.65 -13.34 30.07 -1.72 285.93 128.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for NVO and its peers to uncover potential buy and sell opportunities.